SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Berry Corporation (BRY) , forward earnings yield 19.31%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+114.7%).
- Forward P/E 5.2
- Analyst consensus target $7.00 (+114.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 64/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BRY
Valuation Multiples
P/E (TTM)0.0
Forward P/E5.2
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.32
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.02
Forward EPS (Est.)$0.63
Book Value / Share$0.00
Revenue / Share$10.06
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield19.31%
Dividend Yield0.00%
Analyst Target$7.00 (+114.7%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.00 |
$604.23M |
$-1.02B |
-168% |
| 2016 |
$-15.78 |
$426.77M |
$-1.28B |
-300.7% |
| 2017 |
$-15.92 |
$466.4M |
$-524.03M |
-112.4% |
| 2018 |
$2.54 |
$591.18M |
$147.1M |
24.9% |
| 2019 |
$0.53 |
$597.4M |
$43.54M |
7.3% |
| 2020 |
$-3.29 |
$406.05M |
$-262.9M |
-64.7% |
| 2021 |
$-0.19 |
$701.35M |
$-15.54M |
-2.2% |
| 2022 |
$3.03 |
$1.06B |
$250.17M |
23.7% |
| 2023 |
$0.48 |
$863.45M |
$37.4M |
4.3% |
| 2024 |
$-0.02 |
$776.5M |
$19.25M |
2.5% |
